Alithya Group Inc. (TSX:ALYA)
Canada flag Canada · Delayed Price · Currency is CAD
2.450
+0.040 (1.66%)
Aug 8, 2025, 3:59 PM EDT

Revance Therapeutics Revenue

In the fiscal year ending March 31, 2025, Alithya Group had annual revenue of 473.48M CAD, down -3.59%. Alithya Group had revenue of 125.33M in the quarter ending March 31, 2025, with 3.97% growth.

Revenue
473.48M
Revenue Growth
-3.59%
P/S Ratio
0.52
Revenue / Employee
169.10K
Employees
2,800
Market Cap
244.82M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025473.48M-17.64M-3.59%
Mar 31, 2024491.13M-31.58M-6.04%
Mar 31, 2023522.70M84.82M19.37%
Mar 31, 2022437.89M150.24M52.23%
Mar 31, 2021287.64M8.64M3.10%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Constellation Software14.90B
Celestica14.44B
CGI Inc.15.56B
Topicus.com2.25B
Lumine Group991.65M
The Descartes Systems Group923.60M
Kinaxis701.93M
BlackBerry733.46M
Revenue Rankings